Stereotaxis gains on an upbeat SA article

Stereotaxis (STXS +8.9%) gains from an upbeat article in Seeking Alpha today.

The post, which featured an interview with life science investor DAFNA Capital, calls STXS the leading robotics company in the endovascular space, with the ability to become the 'Intuitive Surgical (ISRG)' of catheter procedures.

DAFNA says ISRG has amongst the highest operating margins in the medical device industry and is an extremely profitable company.

STXS is also a business which can have extremely high profit margins, and when it reaches the appropriate scale to start focusing on profit, the investor thinks that shareholders will be very handsomely rewarded.

Comments (2)
  • User 7325811
    , contributor
    Comment (1) | Send Message
    I am not sure how a company that has never made a profit can be called "extremely profitable". Perhaps they are projecting a possible future scenario where the company produces its own disposable products rather than just a large piece of very expensive capital equipment that is usually only (and rarely) sold in to hospitals planning new labs.


    To my mind, this company must take control of the production and sale of its consumable products if it is to be successful.


    In the present environment, man cannot live by capital alone.


    27 Aug 2013, 01:57 PM Reply Like
  • csv26
    , contributor
    Comments (86) | Send Message
    Hahahahah. Read the quote again.


    27 Aug 2013, 11:49 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs